Fundz

Synnovation Therapeutics reported raising $69.9 Million in an initial SEC Form D filing, from an offering of $102 Million

PRIVATEDec 14, 2023$69.9M of $102.5M raised

Amount Raised

$69.9 Million

$69.9 Million sold, per SEC Form D (first sale Dec 8, 2023)

Round Type

Venture

WilmingtonBiotechnologyHealth CareTherapeuticsPharmaceutical Manufacturing

Quick answer

Synnovation Therapeutics, Inc. raised $69.9 Million in a funding round, dated December 8, 2023. Synnovation Therapeutics, Inc. is based in Wilmington, Delaware, United States.

How much did Synnovation Therapeutics, Inc. raise?
Synnovation Therapeutics, Inc. raised $69.9 Million in a funding round on December 8, 2023.
What does Synnovation Therapeutics, Inc. do?
Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers.
Where is Synnovation Therapeutics, Inc. based and how big is it?
Synnovation Therapeutics, Inc. is based in Wilmington, Delaware, United States.
Who are the decision-makers at Synnovation Therapeutics, Inc?
Fundz holds 1 contact at Synnovation Therapeutics, Inc., including the Executive Officer, Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Pharmaceutical Manufacturing around the same time

Companies in the same sectors as Synnovation Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • BridgeBio raised $1.3B on January 22, 2024.
  • Calidi Biotherapeutics raised $10K on January 19, 2024.
  • Ratio Therapeutics raised $50M (Series B) on January 17, 2024.
  • Gallant raised $15M (Series A) on January 8, 2024.
  • Lykos Therapeutics raised an undisclosed amount (Series A) on January 5, 2024.
  • Liquidia raised $100M (Funding Round) on January 4, 2024.

Who to call at Synnovation Therapeutics, Inc., and when

A new round usually means Synnovation Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Synnovation Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Synnovation Therapeutics, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Synnovation Therapeutics, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Synnovation Therapeutics, Inc.

Location

200 POWDER MILL ROAD

Wilmington, Delaware, United States

About

Synnovation Therapeutics is a precision oncology company focused on small molecule therapies optimized to target key driver mechanisms in cancers. We are dedicated to the discovery and development of first-in-class and best-in-class therapeutics that can improve the lives of people with cancer. Leveraging our deep expertise in medicinal chemistry, cancer biology and patient-focused precision medicine, we are building a diverse pipeline of novel small molecule targeted therapies. Our mission is to efficiently advance these agents into clinical trials with the goal of transforming cancer patient care.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Synnovation Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsWenqing Y., Executive Officer, DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Synnovation Therapeutics, Inc.'s next move

See what Strategic adds

Synnovation Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.